AtaiBeckley Inc. (ATAI) earnings
ATAI earnings moved a median of +0.46% by the close. Quarterly and annual ATAI reports and results, each read against the price at its own news timestamp. Back to the ATAI overview →
18 measured ATAI earnings events.
Where these ATAI earnings landedvs 17 measured ATAI earnings reactions
| Middle 50% of ATAI earnings reactions | -4.10% to +2.50% |
|---|---|
| Median reaction (to close) | +0.46% |
| Measured reactions | 17 |
Point-in-time · zero look-ahead
Half of the 17 ATAI earnings events with a measured close landed between -4.10% and +2.50%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update | Press release | +0.25% | +2.98% | |
| AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights | Press release | +0.35% | +0.46% | |
| Form 10-Q Atai Beckley N.V. For: Sep 30 | SEC filing · Form 10-Q | +0.69% | — | |
| atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates | Press release | +0.23% | +0.75% | |
| Form 10-Q ATAI Life Sciences N.V. For: Jun 30 | SEC filing · Form 10-Q | -1.27% | -1.77% | |
| atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates | Press release | +0.48% | +0.70% | |
| Form 10-Q ATAI Life Sciences N.V. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +13.99% | |
| Form 10-K ATAI Life Sciences N.V. For: Dec 31 | SEC filing · Form 10-K | +0.53% | -4.93% | |
| Form 10-Q/A ATAI Life Sciences N.V. For: Sep 30 | SEC filing · Form 10-Q | -0.33% | +7.33% | |
| atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates | Press release | +2.33% | -10.00% | |
| Form 10-Q ATAI Life Sciences N.V. For: Sep 30 | SEC filing · Form 10-Q | -2.88% | -1.44% | |
| atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates | Press release | +0.41% | +0.00% | |
| Form 10-Q ATAI Life Sciences N.V. For: Jun 30 | SEC filing · Form 10-Q | -1.23% | -4.10% | |
| atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates | Press release | +2.50% | +2.50% | |
| Form 10-Q ATAI Life Sciences N.V. For: Mar 31 | SEC filing · Form 10-Q | +2.50% | +2.50% | |
| Form 10-K ATAI Life Sciences N.V. For: Dec 31 | SEC filing · Form 10-K | -8.88% | -5.58% | |
| atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights | Press release | +1.25% | +4.58% | |
| Form 10-Q ATAI Life Sciences N.V. For: Sep 30 | SEC filing · Form 10-Q | -2.34% | -6.25% |
Keep exploring
More ATAI: analyst actions → · SEC filings → · ATAI overview →
Other Consumer Defensive names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Central Garden & Pet Company (CENT) | 311 | +0.12% | 57% |
| Flowers Foods, Inc. (FLO) | 309 | -0.09% | 44% |
| Boston Beer Company, Inc. (The) (SAM) | 303 | +0.05% | 52% |
| SpartanNash Company (SPTN) | 301 | -0.08% | 34% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.